Pine River Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Pine River Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-461,614	Closed	-$30.3M	–	780
2015 Q4	$30.3M	Buy	461,614 +199,100	+76%	+$12.3M	0.4%	47
2015 Q3	$14.8M	Buy	262,514 +68,288	+35%	+$4.43M	0.19%	112
2015 Q2	$11.5M	Sell	194,226 -190,608	-50%	-$11.8M	0.12%	150
2015 Q1	$24M	Buy	+384,834	New	+$22.4M	0.29%	69
2014 Q3	–	Sell	-76,400	Closed	-$4M	–	1038
2014 Q2	$4M	Buy	76,400 +46,500	+156%	+$2.38M	0.06%	259
2014 Q1	$1.58M	Buy	+29,900	New	+$1.38M	0.02%	404

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Pine River Capital Management's TEVA Position: Q1 2016 in Review

Pine River Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2016, closing a stake of 461,614 shares — an estimated $30.3M sold.

Pine River Capital Management first reported a position in TEVA in Q1 2014 and held it in 6 quarters. The position peaked at $30.3M in Q4 2015. 837 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Pine River Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2016 after selling out during the quarter.
Pine River Capital Management sold 461,614 Teva Pharmaceutical Industries Limited shares in Q1 2016, an estimated $30.3M.
Pine River Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and held it in 6 quarters.
Pine River Capital Management's Teva Pharmaceutical Industries Limited position peaked at $30.3M in Q4 2015.
837 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2016.

Based on Pine River Capital Management's 13F filing for Q1 2016, filed 16 May 2016.